T-cells in mild COVID-19 are increased and cross-talking well, while in critical COVID-19, the peripheral CD4 and CD8 T cells are less abundant and dysregulated, their status was hyperactivated, manifested by increase of Th17 and Th1 cells [37, 38], thereby exacerbating inflammation and tissue damage. The gene discussed is CD8A; the disease is COVID-19.